L1CAM and neoplasm: In Van Gool's study, including high-risk patients (as handled in PORTEC-3) from the TRansPORTEC collaborating institutions, L1CAM-positive tumours (defined as >10%) did not predict prognosis, whereas an alternative threshold (>50%) did [8].